Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (MABs, Recombinant Protein), By Indication (Oncology, CVDs), By Region (Europe, APAC), And Segment Forecasts, 2022 - 2030

Table of content

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Product
  • 1.1.2 Indication
  • 1.1.3 Region
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
• 1.7 List Of Secondary Sources
• 1.8 List Of Primary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective - 1
  • 1.10.2 Objective - 2
  • 1.10.3 Objective - 3
  • 1.10.4 Objective - 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Business Segment Trends
  • 2.3.1 Product Business Analysis
  • 2.3.2 Indication Business Analysis
  • 2.3.3 Regional Business Analysis
• 2.4 Competitive Insights

Chapter 3 Biologics Contract Manufacturing Market: Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Regulatory Framework
• 3.4 Market Variable Analysis
  • 3.4.1 Market Driver Analysis
    • 3.4.1.1 Increasing Outsourcing Activities
    • 3.4.1.2 Rising Demand For Biologics
    • 3.4.1.3 Cost Efficient Services By Cmos In Asia-Pacific Region
  • 3.4.2 Market Restraint Analysis
    • 3.4.2.1 Slow Approvals From Government For Manufacturing In Different Regions
• 3.5 Biologics Contract Manufacturing Market: Analysis Tools
  • 3.5.1 Porter's Five Forces Analysis
  • 3.5.2 Pestel Analysis
  • 3.5.3 Major Deals & Strategic Alliances Analysis
• 3.5 COVID-19 Impact Analysis

Chapter 4 Biologics Contract Manufacturing Market: Product Segment Analysis

• 4.1 Biologics Contract Manufacturing Market: Definition & Scope
• 4.2 Biologics Contract Manufacturing: Market Share Analysis, 2021 & 2030
• 4.3 Mabs
  • 4.3.1 Mabs Market, 2017 - 2030 (USD Million)
• 4.4 Recombinant Proteins
  • 4.4.1 Recombinant Proteins Market, 2017 - 2030 (USD Million)
• 4.5 Others
  • 4.5.1 Others Market, 2017 - 2030 (USD Million)

Chapter 5 Biologics Contract Manufacturing Market: Indication Segment Analysis

• 5.1 Biologics Contract Manufacturing Market : Definition & Scope
• 5.2 Clinical Trial Equipment & Ancillary Solutions: Market Share Analysis, 2021 & 2030
• 5.3 Oncology
  • 5.3.1 Oncology Market, 2017 - 2030 (USD Million)
• 5.4 Immunological Disorders
  • 5.4.1 Immunological Disorders Market, 2017 - 2030 (USD Million)
• 5.5 Cardiovascular Disorders
  • 5.5.1 Cardiovascular Disorders Market, 2017 - 2030 (USD Million)
• 5.6 Hematological Disorders
  • 5.6.1 Hematological Disorders Market, 2017 - 2030 (USD Million)
• 5.7 Others
  • 5.7.1 Others Market, 2017 - 2030 (USD Million)

Chapter 6 : Biologics Contract Manufacturing Market Regional Analysis

• 6.1 Biologics Contract Manufacturing Market: Definition & Scope
• 6.2 Biologics Contract Manufacturing Market: Market Share Analysis, 2021 & 2030
• 6.3 North America
  • 6.3.1 North America Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.3.2 U.S.
    • 6.3.2.1 U.S. Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.3.3 Canada
    • 6.3.3.1 Canada Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
• 6.4 Europe
  • 6.4.1 Europe Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.4.2 France
    • 6.4.2.1 France Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.4.3 U.K.
    • 6.4.3.1 U.K. Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.4.4 Germany
    • 6.4.4.1 Germany Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.4.5 Italy
    • 6.4.5.1 Italy Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.4.6 Spain
    • 6.4.6.1 Spain Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
• 6.5 Asia Pacific
  • 6.5.1 Asia Pacific Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.5.2 Japan
    • 6.5.2.1 Japan Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.5.3 China
    • 6.5.3.1 China Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.5.4 India
    • 6.5.4.1 India Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.5.5 South Korea
    • 6.5.5.1 Korea Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.5.6 Australia
    • 6.5.6.1 Australia Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
• 6.6 Latin America
  • 6.6.1 Latin America Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.6.2 Brazil
    • 6.6.2.1 Brazil Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.6.3 Mexico
    • 6.6.3.1 Mexico Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.6.4 Argentina
    • 6.6.4.1 Argentina Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.6.5 Colombia
    • 6.6.5.1 Colombia Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
• 6.7 MEA
  • 6.7.1 Mea Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.7.2 South Africa
    • 6.7.2.1 South Africa Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.7.3 Saudi Arabia
    • 6.7.3.1 Saudi Arabia Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)
  • 6.7.4 UAE
    • 6.7.4.1 Uae Biologics Contract Manufacturing Market, 2017 - 2030 (USD Million)

Chapter 7 Competitive Analysis

• 7.1 Company Profiles
  • 7.1.1 WuXi Biologics
    • 7.1.1.1 Company Overview
    • 7.1.1.2 Financial Performance
    • 7.1.1.3 Service Benchmarking
    • 7.1.1.4 Strategic Initiatives
  • 7.1.2 Abzena Ltd.
    • 7.1.2.1 Company Overview
    • 7.1.2.2 Financial Performance
    • 7.1.2.3 Service Benchmarking
    • 7.1.2.4 Strategic Initiatives
  • 7.1.3 Fujifilm Diosynth Biotechnologies
    • 7.1.3.1 Company Overview
    • 7.1.3.2 Financial Performance
    • 7.1.3.3 Service Benchmarking
    • 7.1.3.4 Strategic Initiatives
  • 7.1.4 Boehringer Ingelheim BioXcellence
    • 7.1.4.1 Company Overview
    • 7.1.4.2 Financial Performance
    • 7.1.4.3 Service Benchmarking
    • 7.1.4.4 Strategic Initiatives
  • 7.1.5 Lonza
    • 7.1.5.1 Company Overview
    • 7.1.5.2 Financial Performance
    • 7.1.5.3 Service Benchmarking
    • 7.1.5.4 Strategic Initiatives
  • 7.1.6 Samsung Biologics
    • 7.1.6.1 Company Overview
    • 7.1.6.2 Financial Performance
    • 7.1.6.3 Service Benchmarking
    • 7.1.6.4 Strategic Initiatives
  • 7.1.7 AbbVie
    • 7.1.7.1 Company Overview
    • 7.1.7.2 Financial Performance
    • 7.1.7.3 Service Benchmarking
    • 7.1.7.4 Strategic Initiatives
  • 7.1.8 Catalent
    • 7.1.8.1 Company Overview
    • 7.1.8.2 Financial Performance
    • 7.1.8.3 Service Benchmarking
  • 7.1.9 BioReliance
    • 7.1.9.1 Company Overview
    • 7.1.9.2 Financial Performance
    • 7.1.9.3 Service Benchmarking
    • 7.1.9.4 Strategic Initiatives
  • 7.1.10 SE Thermo Fischer (Patheon)
    • 7.1.10.1 Company Overview
    • 7.1.10.2 Service Benchmarking
    • 7.1.10.3 Strategic Initiatives
  • 7.1.11 Eurofins CDMO
    • 7.1.11.1 Company Overview
    • 7.1.11.2 Service Benchmarking
    • 7.1.11.3 Strategic Initiatives

List of Tables

• 1. Table 1 List of Abbreviation
• 2. Table 2 List of Secondary Sources
• 3. Table 3 Global biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 4. Table 4 Global biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 5. Table 5 Global biologics contract manufacturing market, by region, 2017 - 2030 (USD Million)
• 6. Table 6 North America biologics contract manufacturing market, by country, 2017 - 2030 (USD Million)
• 7. Table 7 North America biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 8. Table 8 North America biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 9. Table 9 U.S. biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 10. Table 10 U.S. biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 11. Table 11 Canada biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 12. Table 12 Canada biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 13. Table 13 Europe biologics contract manufacturing market, by country, 2017 - 2030 (USD Million)
• 14. Table 14 Europe biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 15. Table 15 Europe biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 16. Table 16 U.K. biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 17. Table 17 U.K. biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 18. Table 18 Germany biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 19. Table 19 Germany biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 20. Table 20 Spain biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 21. Table 21 Spain biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 22. Table 22 France biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 23. Table 23 France biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 24. Table 24 Italy biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 25. Table 25 Italy biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 26. Table 26 Asia Pacific biologics contract manufacturing market, by country, 2017 - 2030 (USD Million)
• 27. Table 27 Asia Pacific biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 28. Table 28 Asia Pacific biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 29. Table 29 China biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 30. Table 30 China biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 31. Table 31 India biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 32. Table 32 India biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 33. Table 33 Japan biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 34. Table 34 Japan biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 35. Table 35 Australia biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 36. Table 36 Australia biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 37. Table 37 South Korea biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 38. Table 38 South Korea biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 39. Table 39 Latin America biologics contract manufacturing market, by country, 2017 - 2030 (USD Million)
• 40. Table 40 Latin America biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 41. Table 41 Latin America biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 42. Table 42 Brazil biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 43. Table 43 Brazil biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 44. Table 44 Mexico biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 45. Table 45 Mexico biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 46. Table 46 Argentina biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 47. Table 47 Argentina biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 48. Table 48 Colombia biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 49. Table 49 Colombia biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 50. Table 50 MEA biologics contract manufacturing market, by country, 2017 - 2030 (USD Million)
• 51. Table 51 MEA biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 52. Table 52 MEA biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 53. Table 53 South Africa biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 54. Table 54 South Africa biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 55. Table 55 Saudi Arabia biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 56. Table 56 Saudi Arabia biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)
• 57. Table 57 UAE biologics contract manufacturing market, by product, 2017 - 2030 (USD Million)
• 58. Table 58 UAE biologics contract manufacturing market, by indication, 2017 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 QFD modeling for market share assessment
• Fig. 6 Market formulation & validation
• Fig. 7 Commodity flow analysis
• Fig. 8 Biologics contract manufacturing snapshot (2021)
• Fig. 9 Biologics contract manufacturing market segmentation
• Fig. 10 Biologics contract manufacturing market: Strategy framework
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's five forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Biologics contract manufacturing market product: Segment dashboard
• Fig. 19 Biologics contract manufacturing market: Product movement analysis
• Fig. 20 MABs market, 2017 - 2030 (USD Million)
• Fig. 21 Recombinant proteins market, 2017 - 2030 (USD Million)
• Fig. 22 Others market, 2017 - 2030 (USD Million)
• Fig. 23 Biologics contract manufacturing market indication outlook: Segment dashboard
• Fig. 24 Biologics contract manufacturing market: Indication movement analysis
• Fig. 25 Oncology market, 2017 - 2030 (USD Million)
• Fig. 26 Immunological market, 2017 - 2030 (USD Million)
• Fig. 27 Cardiovascular market, 2017 - 2030 (USD Million)
• Fig. 28 Hematological disorders market, 2017 - 2030 (USD Million)
• Fig. 29 Others market, 2017 - 2030 (USD Million)
• Fig. 30 Regional market: Key takeaways
• Fig. 31 Regional outlook, 2020 2030
• Fig. 32 North America market, 2017 - 2030 (USD Million)
• Fig. 33 U.S. market, 2017 - 2030 (USD Million)
• Fig. 34 Canada market, 2017 - 2030 (USD Million)
• Fig. 35 Europe market, 2017 - 2030 (USD Million)
• Fig. 36 U.K. market, 2017 - 2030 (USD Million)
• Fig. 37 Germany market, 2017 - 2030 (USD Million)
• Fig. 38 France market, 2017 - 2030 (USD Million)
• Fig. 39 Italy market, 2017 - 2030 (USD Million)
• Fig. 40 Spain market, 2017 - 2030 (USD Million)
• Fig. 41 Asia Pacific market, 2017 - 2030 (USD Million)
• Fig. 42 Japan market, 2017 - 2030 (USD Million)
• Fig. 43 China market, 2017 - 2030 (USD Million)
• Fig. 44 India market, 2017 - 2030 (USD Million)
• Fig. 45 Australia market, 2017 - 2030 (USD Million)
• Fig. 46 South Korea market, 2017 - 2030 (USD Million)
• Fig. 47 Latin America market, 2017 - 2030 (USD Million)
• Fig. 48 Brazil market, 2017 - 2030 (USD Million)
• Fig. 49 Mexico market, 2017 - 2030 (USD Million)
• Fig. 50 Argentina market, 2017 - 2030 (USD Million)
• Fig. 51 Colombia market, 2017 - 2030 (USD Million)
• Fig. 52 MEA market, 2017 - 2030 (USD Million)
• Fig. 53 South Africa market, 2017 - 2030 (USD Million)
• Fig. 54 Saudi Arabia market, 2017 - 2030 (USD Million)
• Fig. 55 UAE market, 2017 - 2030 (USD Million)